Cargando…
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
Gene therapy has promising applications in ovarian cancer therapy. Blocking the function of the survivin protein could lead to the growth inhibition of cancer cells. Herein, we used degradable heparin–polyethyleneimine (HPEI) nanoparticles to deliver a dominant-negative human survivin T34A (hs-T34A)...
Autores principales: | Luo, Li, Du, Ting, Zhang, Jiumeng, Zhao, Wei, Cheng, Hao, Yang, Yuping, Wu, Yujiao, Wang, Chunmei, Men, Ke, Gou, Maling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745847/ https://www.ncbi.nlm.nih.gov/pubmed/26893558 http://dx.doi.org/10.2147/IJN.S93496 |
Ejemplares similares
-
Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Publicado: (2020) -
Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A
por: Zhang, Ling, et al.
Publicado: (2011) -
A Vesicular Stomatitis Virus‐Inspired DNA Nanocomplex for Ovarian Cancer Therapy
por: Zhao, Wei, et al.
Publicado: (2017) -
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
por: Kang, Tianyi, et al.
Publicado: (2018) -
Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)